What are the glandular causes of hypogonadism and the role of Magnetic Resonance Imaging (MRI) in its diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hypogonadism can result from several glandular causes, including primary testicular failure, pituitary disorders, and hypothalamic dysfunction, and MRI is primarily indicated for suspected secondary hypogonadism when blood tests show low testosterone with inappropriately normal or low gonadotropins (LH/FSH) 1.

Glandular Causes of Hypogonadism

  • Primary causes involve direct testicular damage from conditions like Klinefelter syndrome, orchitis, trauma, or chemotherapy.
  • Secondary hypogonadism stems from pituitary issues such as tumors (prolactinomas, non-functioning adenomas), infiltrative diseases, or hypopituitarism.
  • Tertiary hypogonadism involves hypothalamic dysfunction from Kallmann syndrome, idiopathic hypogonadotropic hypogonadism, or acquired causes like stress or medications.

Role of MRI in Hypogonadism

  • The MRI should focus on the pituitary and hypothalamic regions with thin-slice, contrast-enhanced imaging to detect microadenomas, macroadenomas, empty sella syndrome, or other structural abnormalities.
  • This imaging is crucial when laboratory findings suggest central hypogonadism, especially with symptoms of mass effect like headaches or visual disturbances, or when other pituitary hormone abnormalities are present.
  • MRI findings help guide treatment decisions, as pituitary tumors may require surgical intervention before hormone replacement therapy is initiated, while primary hypogonadism typically doesn't require MRI evaluation 1.

Diagnostic Approach

  • In men with diabetes who have symptoms or signs of hypogonadism, consider screening with a morning serum testosterone level 1.
  • Further testing (such as luteinizing hormone and follicle-stimulating hormone levels) may be needed to distinguish between primary and secondary hypogonadism 1.
  • In men who have total testosterone levels close to the lower limit, it is reasonable to determine free testosterone concentrations either directly from equilibrium dialysis assays or by calculations that use total testosterone, sex hormone binding globulin, and albumin concentrations 1.

From the Research

Glandular Causes of Hypogonadism

  • Hypogonadism can be caused by primary (testicular) or secondary (pituitary-hypothalamic or central) factors 2
  • Secondary hypogonadism is the result of a dysfunction within the hypothalamus and/or pituitary 3
  • Pituitary incidentalomas are common, and patients with microprolactinoma are more likely to present with symptoms of sexual dysfunction while those with macroprolactinoma are more likely to present with symptoms of mass effect 2

Use of MRI in Diagnosing Hypogonadism

  • Pituitary magnetic resonance imaging (MRI) may be necessary when clinically indicated, especially in cases where gonadotropins are low or inappropriately normal 2
  • The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism is significant, with 16.4% of men having abnormal imaging studies 4
  • However, the yield of identifiable abnormalities on pituitary MRI is quite low, and it is not warranted in all patients with hypogonadotropic hypogonadism 5
  • Anatomic lesions are likely to be present only when low levels of total testosterone (<5.2 nmol/L) are found concomitantly with high levels of prolactin and/or low insulin-like growth factor 1 standard deviation score (IGF-1 SDS) 5

Correlation between MRI Findings and Biochemical Parameters

  • There is no correlation between testosterone level and the presence of pituitary anomalies 6
  • Patients with raised prolactin had higher number of abnormal MRI findings and adenomatous lesions compared to men with normal prolactin 5
  • Multivariate logistic regression showed an association of abnormal pituitary MRI with IGF-1 SDS and prolactin 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Male and Female Hypogonadism.

The Nursing clinics of North America, 2018

Research

PITUITARY IMAGING BY MRI AND ITS CORRELATION WITH BIOCHEMICAL PARAMETERS IN THE EVALUATION OF MEN WITH HYPOGONADOTROPIC HYPOGONADISM.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.